Evolutionary struggles between NK cells and viruses

Nature Reviews Immunology

Volumn 8, Issue 4, 2008, Pages 259-268

  Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; DOWN REGULATION; HEPATITIS C; HEPATITIS VIRUS; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; VIRUSES;

EID: 41149093018     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2276     Document Type: Review

References (123)

1. Lanier, L. L. NK cell recognition. Annu. Rev. Immunol 23, 225-274 (2005).
2. Stetson, D. B. et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198, 1069-1076 (2003).
3. Fehniger, T. A. et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811 (2007).
4. Welsh, R. M. & Vargas-Cortes, M. in The Natural Killer Cell (eds. Lewis, C. E. & McGee, J. O. D.) 108-150 (IRL Press, Oxford, UK, 1992).
5. Lodoen, M. B. & Lanier, L. L. Viral modulation of NK cell immunity. Nature Rev. Microbiol. 3, 59-69 (2005).
6. + T cells in vivo by IL-15. Immunity 8, 591-599. (1998).
7. Quinnan, G. V. & Manischewitz, J. E. The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J. Exp. Med. 150, 1549-1554 (1979).
8. Bukowski, J. F., Woda, B. A., Habu, S., Okumura, K. & Welsh, R. M. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131, 1531-1538 (1983).
9. Scalzo, A. A. et al. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149, 581-589 (1992).
10. Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H. & Lanier, L. L. Cutting edge: Ly49D and Ly49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161, 7-10 (1998).
11. Sjolin, H. et al. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195, 825-834 (2002).
12. Brown, M. G. et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292, 934-937. (2001).
13. Daniels, K. A. et al. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194, 29-44 (2001).
14. Lee, H.-S. et al. Susceptibility to mouse cytomegalovirus is associated with depletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nature Genetics 28, 42-45 (2001).
15. Lee, S. H. et al. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197, 515-526 (2003).
16. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326 (2002).
17. Smith, H. R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl Acad. Sci. USA 99, 8826-8831 (2002). References 16 and 17 show that the activating NK-cell receptor Ly49H directly recognizes the MCMV-encoded m157 protein on the surface of MCMV-infected cells, which was the first demonstration of specific cognate recognition of a viral pathogen by NK cells.
18. Dokun, A. O. et al. Specific and nonspecific NK cell activation during virus infection. Nature Immunol 2, 951-956. (2001).
19. Voigt, V. et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl Acad. Sci. USA 100, 13483-13488 (2003).
20. French, A. R. et al. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20, 747-756 (2004). References 19 and 20 show that selective pressures by NK cells expressing the activating Ly49H receptor force mutation of the gene encoding m157 in MCMV.
21. Adams, E. J. et al. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc. Natl Acad. Sci. USA 104, 10128-10133 (2007).
22. Wagner, M., Gutermann, A., Podlech, J., Reddehase, M. J. & Koszinowski, U. H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196, 805-816 (2002).
23. Abi-Rached, L. & Parham, P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J. Exp. Med. 201, 1319-1332 (2005). This is a report on the computational analysis of the sequences of human, primate and mouse NK-cell receptors, which shows that the inhibitory receptors are evolutionarily older than the related activating receptors, and indicates that strong selective pressures, probably mediated by microbial pathogens, are driving the evolution of these mammalian genes.
24. Desrosiers, M. P. et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nature Genet 37, 593-599 (2005). This study shows that resistance to MCMV in Ma/My mice requires genes in both the NKC and MHC class I regions. The activating Ly49P NK-cell receptor from Ma/My mice can only recognize MCMV-infected cells that express H2-Dk.
25. Adam, S. G. et al. Cmv4, a new locus linked to the NK cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice. J. Immunol. 176, 5478-5485 (2006).
26. Rodriguez, M., Sabastian, P., Clark, P. & Brown, M. G. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand white mice. J. Immunol. 173, 6312-6318 (2004).
27. Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197, 1245-1253 (2003).
28. Lodoen, M. et al. The cytomegalovirus m155 gene product subverts NK cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200, 1075-1081 (2004).
29. Lenac, T. et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 203, 1843-1850 (2006).
30. Krmpotic, A. et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201, 211-220 (2005). References 27-30 show that MCMV has evolved several genes to prevent the expression of the host proteins RAE1, MULT1 and H60 in MCMV-infected cells, and that these viral proteins function as virulence factors.
31. Salazar-Mather, T. P., Orange, J. S. & Biron, C. A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187, 1-14 (1998).
32. Hokeness, K. L., Kuziel, W. A., Biron, C. A. & Salazar-Mather, T. P. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174, 1549-1556 (2005).
33. Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA 101, 3516-3521 (2004).
34. Szomolanyi-Tsuda, E., Liang, X., Welsh, R. M., Kurt-Jones, E. A. & Finberg, R. W. Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo. J. Virol. 80, 4286-4291 (2006).
35. Krug, A. et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107-119 (2004).
36. Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503-517 (2007).
37. Andrews, D. M., Scalzo, A. A., Yokoyama, W. M., Smyth, M. J. & Degli-Esposti, M. A. Functional interactions between dendritic cells and NK cells during viral infection. Nature Immunol. 4, 175-181 (2003). This study describes reciprocal and mutually beneficial interactions between NK cells and DCs during infection with MCMV.
38. Dalod, M. et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon α/β. J. Exp. Med. 197, 885-898 (2003).
39. Tay, C. H. & Welsh, R. M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71, 267-275 (1997).
40. Loh, J., Chu, D. T., O'Guin, A. K., Yokoyama, W. M. & Virgin, H. W. Natural killer cells utilize both perforin and γ interferon to regulate murine cytomegalovirus infection in the spleen and liver. J. Virol. 79, 661-667 (2005).
41. Sivori, S. et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl Acad. Sci. USA 101, 10116-10121 (2004).
42. Schmidt, K. N. et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist doublestranded RNA. J. Immunol. 172, 138-143 (2004).
43. Girart, M. V., Fuertes, M. B., Domaica, C. I., Rossi, L. E. & Zwirner, N. W. Engagement of TLR3, TLR7, and NKG2D regulate IFN-γ secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J. Immunol. 179, 3472-3479 (2007).
44. Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522-1527 (2007).
45. Robbins, S. H. et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3, e123 (2007).
46. Su, H. C. et al. NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 31, 3048-3055 (2001).
47. Biron, C. A., Byron, K. S. & Sullivan, J. L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Eng. J. Med. 320, 1731-1735 (1989).
48. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107, 3624-3631 (2005).
49. Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391, 795-798 (1998).
50. Llano, M. et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28, 2854-2863 (1998).
51. Tomasec, P. et al. Surface expression of HLA-E-, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031-1033 (2000).
52. Ulbrecht, M. et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164, 5019-5022 (2000).
53. Wang, E. C. et al. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA 103, 2292-2297 (2002).
54. + T cells: lessons from cytomegalovirus. Viral Immunol. 18, 434-444 (2005).
55. Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133. (2001).
56. Bacon, L. et al. Two Human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 173, 1078-1084 (2004).
57. Chalupny, N. J., Rein-Weston, A., Dosch, S. & Cosman, D. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 346, 175-181 (2006).
58. Stern-Ginossar, N. et al. Host immune system gene targeting by a viral miRNA. Science 317, 376-381 (2007).
59. Zou, Y., Bresnahan, W., Taylor, R. T. & Stastny, P. Effect of human cytomegalovirus on expression of MHC class I-related chains A. J. Immunol. 174, 3098-3104 (2005).
60. Cosman, D. et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273-282 (1997).
61. Chapman, T. L., Heikeman, A. P. & Bjorkman, P. J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11, 603-613 (1999).
62. Leong, C. C. et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I MHC and a viral class I homolog. J. Exp. Med. 187, 1681-1687 (1998).
63. Tomasec, P. et al. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nature Immunol. 6, 181-188 (2005).
64. Arnon, T. I. et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nature Immunol. 6, 515-523 (2005).
65. Lin, A., Xu, H. & Yan, W. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell. Mol. Immunol. 4, 91-98 (2007).
66. Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678 (1986).
67. Carr, W. H., Little, A. M., Mocarski, E. & Parham, P. NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines. Clin. Immunol. 105, 126-140 (2002).
68. Voigt, S. et al. Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 26, 617-627 (2007). This study shows that rat CMV encodes a viral protein related to the C-type lectin family that engages the inhibitory NKR-P1B receptor in strains of rats that are susceptible to CMV infection.
69. Pereira, R. A., Scalzo, A. & Simmons, A. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J. Immunol. 166, 5869-5873. (2001).
70. Lundberg, P. et al. A locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice. J. Virol. 77, 11661-11673 (2003).
71. Etzioni, A. et al. Fatal varicella associated with selective natural killer cell deficiency. J. Pediatr. 146, 423-425 (2005).
72. Pappworth, I. Y., Wang, E. C. & Rowe, M. The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing. J. Virol. 81, 474-482 (2007).
73. Eidenschenk, C. et al. A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am. J. Hum. Genet. 78, 721-727 (2006).
74. Besson, C. et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. PLoS ONE 2, e406 (2007).
75. Jacoby, R. O., Bhatt, P. N. & Brownstein, D. G. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch. Virol. 108, 49-58 (1989).
76. Delano, M. L. & Brownstein, D. G. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus-replication by cells with an NK phenotype. J. Virol. 69, 5875-5877 (1995).
77. Chaudhri, G., Panchanathan, V., Bluethmann, H. & Karupiah, G. Obligatory requirement for antibody in recovery from a primary poxvirus infection. J. Virol. 80, 6339-6344 (2006).
78. + T cells are complementary and essential for natural resistance to a highly lethal cytopathic virus. J. Immunol. 175, 6829-6836 (2005).
79. Karupiah, G. et al. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1448 (1993).
80. Panchanathan, V., Chaudhri, G. & Karupiah, G. Interferon function is not required for recovery from a secondary poxvirus infection. Proc. Natl Acad. Sci. USA 102, 12921-12926 (2005).
81. Fang, M., Lanier, L. L. & Sigal, L. J. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathogen 8, e30 (2008).
82. Chisholm, S. E. & Reyburn, H. T. Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors. J. Virol. 80, 2225-2233 (2006).
83. Brooks, C. R., Elliott, T., Parham, P. & Khakoo, S. I. The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells. J. Immunol. 176, 1141-1147 (2006).
84. Campbell, J. A., Trossman, D. S., Yokoyama, W. M. & Carayannopoulos, L. N. Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J. Exp. Med. 204, 1311-1317 (2007).
85. Draghi, M. et al. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178, 2688-2698 (2007).
86. Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060 (2001).
87. Gazit, R. et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nature Immunol. 7, 517-523 (2006).
88. Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874 (2004). This study provides intriguing hints that the resolution of HCV infection in humans involves cooperative interactions between certain HLA-C molecules and inhibitory KIRs.
89. Vilches, C. & Parham, P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20, 217-251 (2002).
90. Crotta, S. et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35-41 (2002).
91. Tseng, C. T. & Klimpel, G. R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43-49 (2002).
92. Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930 (2000).
93. Baron, J. L. et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583-594 (2002).
94. Chen, Y. et al. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46, 706-715 (2007).
95. Vilarinho, S., Ogasawara, K., Nishimura, S., Lanier, L. L. & Baron, J. L. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc. Natl Acad. Sci. USA 104, 18187-18192 (2007).
96. Martin, M. P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nature Genet. 39, 733-740 (2007). A population-based study that implicates HLA-B and certain KIRs in protection against progression to AIDS in HIV-infected individuals.
97. Flores-Villanueva, P. O. et al. Control of HIV-1 viremia and protection from AIDS are associated with HLABw4 homozygosity. Proc. Natl Acad. Sci. USA 98, 5140-5145 (2001).
98. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H. & Lanier, L. L. NKB1: An NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180, 537-543 (1994).
99. Carr, W. H. et al. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178, 647-651 (2007).
100. Trundley, A., Frebel, H., Jones, D., Chang, C. & Trowsdale, J. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 37, 780-787 (2007).
101. Qi, Y. et al. KIR/HLA Pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2, e79 (2006).
102. Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. & Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133-1144 (1995).
103. + T cell epitopes. AIDS Res. Hum. Retroviruses 23, 451-455 (2007).
104. Alter, G. et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204, 3027-3036 (2007).
105. Pando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L. & Parham, P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J. Immunol. 171, 6640-6649 (2003).
106. Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671 (1999).
107. Cerboni, C. et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 88, 242-250 (2007).
108. + cells are early IFN-γ producers but impair resistance to Listeria monocytogenes infection. J. Immunol. 152, 1873-1882 (1994).
109. Sporri, R., Joller, N., Albers, U., Hilbi, H. & Oxenius, A. MyD88-dependent IFN-γ production by NK cells is key for control of Legionella pneumophila infection. J. Immunol. 176, 6162-6171 (2006).
110. Junqueira-Kipnis, A. P. et al. NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection. J. Immunol. 171, 6039-6045 (2003).
111. Feng, C. G. et al. NK Cell-Derived IFN-γ differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177, 7086-7093 (2006).
112. Vankayalapati, R. et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175, 4611-4617 (2005).
113. Le-Barillec, K. et al. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol. 175, 1735-1740 (2005).
114. Brown, C. R. & Reiner, S. L. Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection. Infect. Immun. 66, 5208-5214 (1998).
115. Babu, S., Porte, P., Klei, T. R., Shultz, L. D. & Rajan, T. V. Host NK cells required for the growth of the human filarial parasite Brugia malayi in mice. J. Immunol. 161, 1428-1432 (1998).
116. Laouar, Y., Sutterwala, F. S., Gorelik, L. & Flavell, R. A. Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nature Immunol. 6, 600-607 (2005).
117. Schleicher, U. et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med. 204, 893-906 (2007).
118. Sher, A., Oswald, I. P., Hieny, S. & Gazzinelli, R. T. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150, 3982-3989 (1993).
119. Hunter, C. A., Subauste, C. S., Van Cleave, V. H. & Remington, J. S. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin- 12, and tumor necrosis factor α. Infect. Immun. 62, 2818-2824 (1994).
120. Ma, L. L. et al. NK cells use perforin rather than granulysin for anticryptococcal activity. J. Immunol. 173, 3357-3365 (2004).
121. Duthie, M. S. & Kahn, S. J. NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection. Int. Immunol. 17, 607-613 (2005).
122. Roland, J. et al. NK cell responses to Plasmodium infection and control of intrahepatic parasite development. J. Immunol. 177, 1229-1239 (2006).
123. Hansen, D. S., D'Ombrain, M. C. & Schofield, L. The role of leukocytes bearing Natural Killer Complex receptors and Killer Immunoglobulin-like Receptors in the immunology of malaria. Curr. Opin. Immunol. 19, 416-423 (2007).